Model: | Ratio |
Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 81936 | 0.0386 | 40.25 | 4673918 |
NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 221645 | 0.0345 | 112.22 | 1417399 |
Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
RSI Period: | 14 | RSI Threshold: | 0 | ||
Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 |
Initial Capital: | 10000.00 | Final Equity: | 10137.76 |
Total net P/L: | 137.76 | Total ROI: | 1.38 % |
CAGR: | 8.68 % | Max. DD: | 1.59 % |
System Score: | 2.374 | Sharpe Ratio: | 0.426 |
Start Date: | 2010-04-01 | End Date: | 2010-05-31 |
Total days: | 60 | ||
Commissions: | 15.64 | Comm.% P/L | 10.20 % |
Total Transactions: | 12 | Log. Linearity: | 64.910 % |
Total | ![]() |
![]() |
GSK | NVS | |
---|---|---|---|---|---|
Total Profit/Loss | 153.40 | 155.91 | -2.51 | 672.48 | -519.08 |
Total Profit | 161.82 | 155.91 | 5.91 | 672.48 | 24.35 |
Total Loss | 8.42 | 0.00 | 8.42 | 0.00 | 543.43 |
Profit Factor | 19.23 | 0.00 | 0.70 | 0.00 | 0.04 |
Trades | 3 | 1 | 2 | 3 | 3 |
Winning Trades | 2 | 1 | 1 | 3 | 1 |
Losing Trades | 1 | 0 | 1 | 0 | 2 |
% Profitable | 66.00 | 100.00 | 50.00 | 100.00 | 33.00 |
Profit/Loss Per Trade % | 0.51 | 1.56 | -0.01 | 2.23 | -1.73 |
Profit Per Trade % | 0.81 | 1.56 | 0.06 | 2.23 | 0.24 |
Loss Per Trade % | 0.08 | 0.00 | 0.08 | 0.00 | 2.70 |
Days In Trade | 38 | 5 | 33 | 38 | 38 |
Days In Trade (Avg. Per Trade) | 12.67 | 5.00 | 16.50 | 12.67 | 12.67 |
% Days In Trade | 63.33 | 8.33 | 55.00 | 63.33 | 63.33 |